Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001671311-25-000003

Chief Operating Officer sold 50,292 shares at an average $14.92 ($750,412)

  • Chief Operating Officer acquired 50,292 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jarrett Jennifer Chief Operating Officer 2025-10-06 Option exercise 10b5-1 +12,500 $1.23 $15,345 226,732 D: show line 1 in the form
Jarrett Jennifer Chief Operating Officer 2025-10-06 Sale 10b5-1 −12,500 $14.54 $181,801 214,232 D: show line 2 in the form
Jarrett Jennifer Chief Operating Officer 2025-10-08 Option exercise 10b5-1 +37,792 $1.23 $46,393 252,024 D: show line 3 in the form
Jarrett Jennifer Chief Operating Officer 2025-10-08 Sale 10b5-1 −37,792 $15.05 $568,611 214,232 D: show line 4 in the form
Open-market sales · 50,292 sh · avg $14.92 · $750,412

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jarrett Jennifer Chief Operating Officer 2025-10-06 Option exercise · Stock Option (Right to Buy) 10b5-1 −12,500 168,666 D: show line 5 in the form
Jarrett Jennifer Chief Operating Officer 2025-10-08 Option exercise · Stock Option (Right to Buy) 10b5-1 −37,792 130,874 D: show line 6 in the form
Loading xslF345X05/wk-form4_1759964895.xml…